Boobalan Pachaiyappan
Stock Analyst at Roth Capital
(0.66)
# 2451
Out of 5,358 analysts
12
Total ratings
50.00%
Success rate
-4.33%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
PYPD PolyPid | Initiates Coverage On: Buy | 9 | 3.25 | 176.92% | 1 | Jun 5, 2025 | |
CING Cingulate | Maintains: Buy | 12 11 | 4.39 | 150.57% | 2 | May 19, 2025 | |
CRVO CervoMed | Maintains: Strong Buy | 15 20 | 7.55 | 164.9% | 3 | Mar 18, 2025 | |
VRNA Verona Pharma | Initiates Coverage On: Buy | 68 | 84.35 | -19.38% | 1 | Jan 10, 2025 | |
RVPH Reviva Pharmaceutica... | Initiates Coverage On: Buy | 7 | 0.82 | 753.66% | 1 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 7 | 1.91 | 266.49% | 2 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 8.32 | 248.56% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.23 | 713.01% | 1 | Dec 5, 2024 |